Repare Therapeutics Inc.
RPTX
$1.36
$0.118.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.71% | 13.73% | -2,121.82% | -56.32% | -222.91% |
| Total Depreciation and Amortization | -1.54% | 3.84% | 5.67% | 5.68% | -1.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.57% | -19.94% | -12.72% | -12.75% | -13.56% |
| Change in Net Operating Assets | 74.53% | 72.71% | -11.37% | -3,099.95% | -1,352.74% |
| Cash from Operations | 39.88% | 39.93% | -945.96% | -5,622.91% | -39,590.06% |
| Capital Expenditure | -- | -321.11% | -362.79% | -147.97% | -221.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.15% | -37.33% | 128.46% | 136.14% | 145.66% |
| Cash from Investing | -36.61% | -37.97% | 128.18% | 135.22% | 144.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.63% | -28.38% | -13.87% | -23.57% | -4.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.63% | -28.38% | -13.87% | -23.57% | -4.32% |
| Foreign Exchange rate Adjustments | -627.27% | 113.77% | 83.52% | 95.27% | 106.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.98% | 43.90% | 77.71% | 90.07% | 72.41% |